Log in
NASDAQ:MTP

Midatech Pharma Stock Forecast, Price & News

$1.82
-0.01 (-0.55 %)
(As of 11/27/2020 12:00 AM ET)
Add
Compare
Today's Range
$1.82
Now: $1.82
$1.86
50-Day Range
$1.77
MA: $1.91
$2.36
52-Week Range
$0.86
Now: $1.82
$7.07
Volume61,074 shs
Average Volume1.95 million shs
Market Capitalization$22.95 million
P/E RatioN/A
Dividend YieldN/A
Beta2.86
Midatech Pharma Plc is a drug delivery technology company. It is focused on the research and development of medicines for rare cancers, via both in house programmes as well as partnered programmes. The firm's proprietary platform drug delivery technologies are Q-Sphera platform is a disruptive polymer microsphere technology, which is used for sustained release at the microscale to prolong and control the release of therapeutics over an extended period of time from weeks to months; Midasolve platform is a innovative nanosaccharide technology, which is used to dissolve drugs at the nanoscale so that they can be administered in liquid form directly and locally into tumors; Midacore platform is a edge gold nanoparticle technology, which is used for targeting sites of disease at the nanoscale ie i. chemotherapy - improved and targeted delivery of existing chemotherapeutic agents to tumor sites, as well as ii. immunotherapy - enhanced uptake of new immuno-moieties by immune cells that can then mount an immune attack against cancer cells. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.73 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:MTP
CUSIPN/A
Phone441235888300
Employees65

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$860,000.00
Book Value$40.82 per share

Profitability

Miscellaneous

Market Cap$22.95 million
Next Earnings DateN/A
OptionableNot Optionable
$1.82
-0.01 (-0.55 %)
(As of 11/27/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MTP News and Ratings via Email

Sign-up to receive the latest news and ratings for MTP and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Midatech Pharma (NASDAQ:MTP) Frequently Asked Questions

How has Midatech Pharma's stock been impacted by Coronavirus (COVID-19)?

Midatech Pharma's stock was trading at $3.12 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, MTP shares have decreased by 41.7% and is now trading at $1.82.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than Midatech Pharma?

Wall Street analysts have given Midatech Pharma a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Midatech Pharma wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Midatech Pharma?

Midatech Pharma saw a increase in short interest in the month of October. As of October 30th, there was short interest totaling 155,400 shares, an increase of 50.0% from the October 15th total of 103,600 shares. Based on an average daily volume of 3,220,000 shares, the days-to-cover ratio is currently 0.0 days.
View Midatech Pharma's Short Interest
.

Who are some of Midatech Pharma's key competitors?

What other stocks do shareholders of Midatech Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Midatech Pharma investors own include CRISPR Therapeutics (CRSP), Corbus Pharmaceuticals (CRBP), Pfizer (PFE), Vaxart (VXRT), Nabriva Therapeutics (NBRV), Novavax (NVAX), Plug Power (PLUG), SCYNEXIS (SCYX), Sangamo Therapeutics (SGMO) and Sorrento Therapeutics (SRNE).

Who are Midatech Pharma's key executives?

Midatech Pharma's management team includes the following people:
  • Stephen Anthony Stamp, Director, Chief Executive & Financial Officer
  • Steve Damment, Head-Research & Development

What is Midatech Pharma's stock symbol?

Midatech Pharma trades on the NASDAQ under the ticker symbol "MTP."

Who are Midatech Pharma's major shareholders?

Midatech Pharma's stock is owned by a variety of retail and institutional investors. Top institutional investors include Morgan Stanley (0.46%) and Wedbush Securities Inc. (0.11%).

Which major investors are buying Midatech Pharma stock?

MTP stock was acquired by a variety of institutional investors in the last quarter, including Morgan Stanley, and Wedbush Securities Inc..

How do I buy shares of Midatech Pharma?

Shares of MTP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Midatech Pharma's stock price today?

One share of MTP stock can currently be purchased for approximately $1.82.

How big of a company is Midatech Pharma?

Midatech Pharma has a market capitalization of $22.95 million and generates $860,000.00 in revenue each year. Midatech Pharma employs 65 workers across the globe.

What is Midatech Pharma's official website?

The official website for Midatech Pharma is www.midatechpharma.com.

How can I contact Midatech Pharma?

Midatech Pharma's mailing address is ODDFELLOWS HOUSE 19 NEWPORT ROAD, CARDIFF X0, CF24 0AA. The company can be reached via phone at 441235888300 or via email at [email protected]

This page was last updated on 11/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.